Action Pharma In New Phase II Clinical Trial

Full story: MediLexicon

Main Category: Urology / Nephrology Also Included In: Pharma Industry / Biotech Industry Action Pharma has initiated a new clinical phase II trial for it's leading development candidate AP214, investigating the effect of AP214 on organ protection in patients undergoing cardiac surgery, who are at increased risk of kidney injury.

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Thoracic Surgery Discussions

Topic	Updated	Last By	Comments
Surgical Staplers used in VATS (Jun '07)	Nov '09	FTac	9
Hospital recognized for bypass successes (Apr '09)	Apr '09	Larry	1
CyberKnife Radiosurgery For Lung Cancer Sees In... (Mar '09)	Mar '09	gdpawel	1
Change coming (Feb '09)	Feb '09	Flock Off	1
'Mistake' to privatise IJN (Dec '08)	Dec '08	swastakan se...	3
Air gun Pellet lodge in upper lobe of my daught... (Nov '08)	Nov '08	Richard Wins...	1
Bronchopulmonary sequestration (Oct '08)	Oct '08	Evan Charles	1